MedTrace Logo

The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis

NCT00430599 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-10-12

No results posted yet for this study

Summary

We are carrying out this study to determine whether Keppra (a drug usually used to treat epilepsy) is an effective treatment for tremor in patients with Multiple Sclerosis. Tremor is one of the most common symptoms in MS, but also one of the most difficult to treat. A very small previous study has indicated that Keppra may be effective in this role, but we need to reproduce these results in many more patients before we can reliably confirm this.

Conditions

Sponsors & Collaborators

  • Newcastle-upon-Tyne Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Dr P Nichols, MRCP, DPhil · Newcastle NHS Hospitals Trust

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Completion
2009-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00430599 on ClinicalTrials.gov